BIEL (Bioelectronics) FCF Margin %: 0.00% (As of . 20)


What is Bioelectronics FCF Margin %?

Bioelectronics BIEL -16.67% FCF Margin % is 0.00% as of . 20.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bioelectronics's Free Cash Flow for the three months ended in . 20 was $0.00 Mil. Bioelectronics's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Bioelectronics's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Bioelectronics's current FCF Yield % is 0.00%.

The historical rank and industry rank for Bioelectronics's FCF Margin % or its related term are showing as below:


BIEL's FCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.03
* Ranked among companies with meaningful FCF Margin % only.

Bioelectronics FCF Margin % Related Terms

Bioelectronics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bioelectronics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics FCF Margin % Chart

Bioelectronics Annual Data
Trend
FCF Margin %

Bioelectronics Quarterly Data
FCF Margin %

BIEL vs NUVPF, ADMD, RSPI: FCF Margin % Comparison

For the Medical Devices subindustry, Bioelectronics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioelectronics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioelectronics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bioelectronics's FCF Margin % falls into.


Bioelectronics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bioelectronics's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Bioelectronics's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Bioelectronics (BIEL) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioelectronics and its competitors.
Is Bioelectronics' FCF Margin % too high?
Bioelectronics' current FCF Margin % is 0.00%.
How does Bioelectronics' FCF Margin % compare to NUVPF and ADMD?
Bioelectronics' FCF Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bioelectronics and its competitors. Bioelectronics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioelectronics stock overvalued right now?
Bioelectronics (BIEL) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bioelectronics (BIEL), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.